Operating Income (Loss) in USD of SUTRO BIOPHARMA, INC. from 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Sutro Biopharma, Inc. quarterly/annual Operating Income (Loss) history and change rate from 2016 to Q3 2025.
  • Sutro Biopharma, Inc. Operating Income (Loss) for the quarter ending 30 Sep 2025 was -$48.5M, a 28.7% increase year-over-year.
  • Sutro Biopharma, Inc. Operating Income (Loss) for the twelve months ending 30 Sep 2025 was -$186M, a 42.7% decline year-over-year.
  • Sutro Biopharma, Inc. annual Operating Income (Loss) for 2024 was -$238M, a 167% decline from 2023.
  • Sutro Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$89.3M, a 30.8% increase from 2022.
  • Sutro Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$129M, a 30.9% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Change (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Change (%)

SUTRO BIOPHARMA, INC. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$186M -$48.5M +$19.5M +28.7% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 -$205M -$3.35M +$45.3M +93.1% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 -$250M -$68.5M -$11.9M -21.1% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 -$238M -$65.3M -$108M -251% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 -$130M -$67.9M -$23.9M -54.3% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 -$106M -$48.7M -$2.51M -5.43% 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 -$104M -$56.6M -$14.4M -34% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q4 2023 -$89.3M $43.2M +$92.4M 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025
Q3 2023 -$182M -$44M -$22.8M -108% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 -$159M -$46.2M -$26.8M -138% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 -$132M -$42.2M -$3.11M -7.94% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 -$129M -$49.2M -$14.2M -40.5% 01 Oct 2022 31 Dec 2022 10-K 13 Mar 2025
Q3 2022 -$115M -$21.2M +$13.5M +38.8% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 -$128M -$19.4M -$9.57M -97.6% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$119M -$39.1M -$20.1M -106% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 -$98.5M -$35M -$10.2M -41% 01 Oct 2021 31 Dec 2021 10-K 25 Mar 2024
Q3 2021 -$88.3M -$34.7M -$24.1M -227% 01 Jul 2021 30 Sep 2021 10-Q 08 Nov 2022
Q2 2021 -$64.3M -$9.81M +$6.61M +40.3% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022
Q1 2021 -$70.9M -$19M +$171K +0.89% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022
Q4 2020 -$71.1M -$24.8M -$10.1M -68.1% 01 Oct 2020 31 Dec 2020 10-K 30 Mar 2023
Q3 2020 -$61M -$10.6M +$2.12M +16.6% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 -$63.1M -$16.4M -$2.73M -20% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021
Q1 2020 -$60.4M -$19.2M -$4.91M -34.4% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 -$55.5M -$14.8M -$11.5M -351% 01 Oct 2019 31 Dec 2019 10-K 28 Feb 2022
Q3 2019 -$44M -$12.7M -$2.58M -25.4% 01 Jul 2019 30 Sep 2019 10-Q 05 Nov 2020
Q2 2019 -$41.4M -$13.7M -$1.6M -13.2% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 -$39.8M -$14.3M -$2.56M -21.9% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$37.2M -$3.28M 01 Oct 2018 31 Dec 2018 10-K 18 Mar 2021
Q3 2018 -$10.2M -$9.09M -854% 01 Jul 2018 30 Sep 2018 10-Q 08 Nov 2019
Q2 2018 -$12.1M 01 Apr 2018 30 Jun 2018 10-Q 14 Aug 2019
Q1 2018 -$11.7M 01 Jan 2018 31 Mar 2018 10-Q 15 May 2019
Q3 2017 -$1.07M 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018

SUTRO BIOPHARMA, INC. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$238M -$149M -167% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
2023 -$89.3M +$39.7M +30.8% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025
2022 -$129M -$30.4M -30.9% 01 Jan 2022 31 Dec 2022 10-K 13 Mar 2025
2021 -$98.5M -$27.5M -38.7% 01 Jan 2021 31 Dec 2021 10-K 25 Mar 2024
2020 -$71.1M -$15.6M -28.1% 01 Jan 2020 31 Dec 2020 10-K 30 Mar 2023
2019 -$55.5M -$18.2M -49% 01 Jan 2019 31 Dec 2019 10-K 28 Feb 2022
2018 -$37.2M -$18M -93.1% 01 Jan 2018 31 Dec 2018 10-K 18 Mar 2021
2017 -$19.3M -$20.6M -1513% 01 Jan 2017 31 Dec 2017 10-K 16 Mar 2020
2016 $1.36M 01 Jan 2016 31 Dec 2016 10-K 01 Apr 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.